Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 15/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4129170 | 1.00 | PTGDR2 (0.72) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4129166 | 1.00 | PTGDR2 (0.72) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4133799 | 1.00 | PTGDR2 (0.72) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4128457 | 0.92 | PTGDR2 (0.69) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4128459 | 0.92 | PTGDR2 (0.69) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4137487 | 0.92 | PTGDR2 (0.69) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5408158 | 0.89 | PTGDR2 (0.70) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5408167 | 0.89 | PTGDR2 (0.70) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5408161 | 0.89 | PTGDR2 (0.70) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4129221 | 0.88 | PTGDR2 (0.69) | PTGDR2MEN1KMT2ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1740547-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005100321-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
| EP-1556047-A2 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004032848-A2 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2004-04-22 | — | — | WO | disclosed |